Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Atopic Dermatitis · Seborrheic Keratosis · ACRS

Aclaris Therapeutics

Aclaris Therapeutics trial registry — 38 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
170 N Radnor Chester Rd, Radnor Township, Pennsylvania, US HQ
2012 Founded
10 Employees
Public company Type
ACRS · NYSE Ticker
Company details
Status
Public
HQ
170 N Radnor Chester Rd, Radnor Township, Pennsylvania, US
Founded
2012
Employees
10
Programs
33
Drugs
12
Patents
18
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Trials

Aclaris Therapeutics clinical trials

Registry index of 38 ClinicalTrials.gov studies linked to Aclaris Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Aclaris Therapeutics trial registry — 38 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Aclaris Therapeutics.

  1. ATI-052-ASTH-101 — Phase 1

    Clinical update

  2. ATI 502 0.46% Topical Solution — Phase 2

    Clinical update

  3. Active — Phase 3

    Clinical update

  4. ATI-045, Placebo to ATI-045 — Phase 2

    Clinical update

  5. ATI-501 400mg BID (Low dose) — Phase 2

    Clinical update

  6. ATI-50002 topical solution — Phase 2

    Clinical update

  7. ATI-50002 high dose — Phase 2

    Clinical update

  8. ATI-50002 — Phase 2

    Clinical update

Trial registry

38 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.